GlassScriptPhysician profile
Reinaldo M Gutierrez
NPI 1356346373
$4,804.76
in general payments reported to CMS, 2019-2025
38 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $937 · 2020: $507 · 2021: $788 · 2022: $893 · 2023: $611 · 2024: $546 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $924.24 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $700.08 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $420.01 | 2019-2023 | Belsomra, Steglatro |
| Novo Nordisk INC | $394.38 | 2019-2025 | Wegovy |
| Pfizer INC. | $276.37 | 2019-2024 | |
| Amgen INC. | $199.50 | 2019-2025 | Repatha, Otezla, Repatha |
| Intercept Pharmaceuticals, INC. | $177.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $169.43 | 2019-2022 | |
| Atricure, INC. | $144.90 | 2020 | |
| Renalytix Ai, INC. | $140.96 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Medtronic, INC. | $139.75 | 2023 | Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.16 | 2019-2024 | |
| Echosens North America, INC. | $104.16 | 2025 | Fibroscan |
| Medtronic USA, INC. | $97.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $89.05 | 2019-2024 | Farxiga, Airsupra |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reinaldo Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.